Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

10.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
The Proteasome01:13

The Proteasome

1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Department Chair Allyship With Scholarly Productivity of Underrepresented in Family Medicine Faculty: A CERA Study.

PRiMER (Leawood, Kan.)·2026
Same author

Primary Care and Cross-Cultural Care.

Primary care·2026
Same author

An Emerging Issue in Journal Publishing: The Use of Artificial Intelligence to Generate Letters to the Editor.

PRiMER (Leawood, Kan.)·2026
Same author

Qualitative Methods for Medical Education Research.

PRiMER (Leawood, Kan.)·2025
Same author

Storylines of family medicine IV: perspectives on practice-lenses of appreciation.

Family medicine and community health·2024
Same author

Multiple Subthreshold GPCR Signals Combined by the G-Proteins Gα<sub>q</sub> and Gα<sub>s</sub> Activate the <i>Caenorhabditis elegans</i> Egg-Laying Muscles.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2023

Related Experiment Video

Updated: Apr 30, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

4.5K

Novel polyglutamine model uncouples proteotoxicity from aging.

Nakeirah T M Christie1, Amy L Lee1, Hannah G Fay1

  • 1Biology Department, The University of the South, Sewanee, Tennessee, United States of America.

Plos One
|May 13, 2014
PubMed
Summary
This summary is machine-generated.

Researchers developed a new C. elegans model for Machado-Joseph Disease (MJD), revealing that ataxin-3 protein aggregation causes cellular dysfunction independently of aging.

More Related Videos

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

2.1K
Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

13.1K

Related Experiment Videos

Last Updated: Apr 30, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

4.5K
Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

2.1K
Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

13.1K

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Polyglutamine expansions in proteins cause neurodegenerative disorders.
  • Protein aggregation and toxicity drive neurodegeneration.
  • Machado-Joseph Disease (MJD), or spinocerebellar ataxia 3 (SCA3), is linked to ataxin-3 polyglutamine expansions.

Purpose of the Study:

  • Elucidate the mechanisms of ataxin-3 toxicity.
  • Develop a novel model for studying ataxin-3 aggregation and toxicity.

Main Methods:

  • Expressed a disease-related polyglutamine-containing ataxin-3 fragment in C. elegans body wall muscle cells.
  • Observed polyglutamine-dependent aggregation and cellular dysfunction.
  • Assessed the influence of aging on aggregation and toxicity.

Main Results:

  • Ataxin-3 fragment aggregation occurred in a polyglutamine length-dependent manner in C. elegans.
  • Aggregation was associated with cellular dysfunction.
  • Surprisingly, aggregation and toxicity were not influenced by aging, unlike polyglutamine peptides alone.

Conclusions:

  • The study presents a new C. elegans model for ataxin-3 aggregation.
  • Protein context influences polyglutamine-containing protein interactions and toxicity.
  • This suggests that protein structure modulates age-independent aggregation and toxicity in neurodegenerative diseases.